SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-260378
Filing Date
2019-10-02
Accepted
2019-10-02 08:36:08
Documents
3
Period of Report
2019-11-12
Effectiveness Date
2019-10-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A d770160ddef14a.htm DEF 14A 676052
2 GRAPHIC g770160g74y67.jpg GRAPHIC 25251
3 GRAPHIC g770160g81n30.jpg GRAPHIC 26789
  Complete submission text file 0001193125-19-260378.txt   749061
Mailing Address 401 TERRY AVENUE NORTH SEATTLE WA 98109
Business Address 401 TERRY AVENUE NORTH SEATTLE WA 98109 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36327 | Film No.: 191130862
SIC: 2834 Pharmaceutical Preparations